NYSE: CNKCinemark Holdings Inc Stock
$29.91+0.14 (+0.47%)
Updated Apr 30, 2025
CNK Price
$29.91
Fair Value Price
N/A
Market Cap
$3.66B
52 Week Low
$16.32
52 Week High
$36.28
P/E
11.78x
P/B
6.15x
P/S
1.22x
PEG
N/A
Dividend Yield
0.27%
Revenue
$3.05B
Earnings
$309.70M
Gross Margin
38.7%
Operating Margin
13.63%
Profit Margin
10.2%
Debt to Equity
7.51
Operating Cash Flow
$466M
Beta
1.12
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CNK Overview
Cinemark Holdings, Inc. operates movie theaters (4,600 screens in 37 states and Latin America). Its brands include Century, Tinseltown, and Rave. Most of Cinemark's theaters are located in midsize cities or suburbs of large cities. The company was founded in 1984 and is headquartered in Plano, TX.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CNK's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important CNK news, forecast changes, insider trades & much more!
CNK News
Overview
Due Diligence Score
–
Industry Average (22)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CNK scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CNK is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CNK is good value based on its earnings relative to its share price (11.78x), compared to the US market average (29.18x)
P/E vs Market Valuation
CNK is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CNK due diligence checks available for Premium users.
Valuation
CNK price to earnings (PE)
For valuing profitable companies with steady earnings
Company
11.78x
Industry
80.97x
Market
29.18x
CNK is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CNK is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CNK price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
6.15x
Industry
3.75x
CNK is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CNK's financial health
Profit margin
Revenue
$814.3M
Net Income
$51.3M
Profit Margin
6.3%
CNK's Earnings (EBIT) of $415.60M... subscribe to Premium to read more.
Interest Coverage Financials
CNK's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$5.1B
Liabilities
$4.5B
Debt to equity
7.51
CNK's short-term assets ($1.30B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CNK's long-term liabilities ($3.18B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CNK's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CNK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$196.4M
Investing
-$57.8M
Financing
-$8.4M
CNK's operating cash flow ($466.00M)... subscribe to Premium to read more.
Debt Coverage Financials
CNK vs Entertainment Stocks
Cinemark Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.